Register Cart 0

Generic placeholder image

Current Drug Therapy

Editor-in-Chief

ISSN (Print): 1574-8855
ISSN (Online): 2212-3903

Back Subscribe

Biography

Meet Our Editorial Board Member

Author(s): Stefano Angioni*

Volume 12, Issue 1, 2017

Page: [1 - 1] Pages: 1

DOI: 10.2174/157488551201170502190936

conference banner

Next »

Rights & Permissions Print Cite

Article Metrics

13

Wayfinder Image

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies
Current Pharmacogenomics and Personalized Medicine

Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application
Current Gene Therapy

Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
Mini-Reviews in Medicinal Chemistry

Focused Microarray Analysis: Characterization of Phenomes by Gene Expression Profiling
Current Pharmacogenomics

Recurrence in Bladder Cancer: A Molecular Dead End?
Current Genomics

Role of Cytokines in Regulating Feeding Behaviour
Current Drug Targets

Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry

A Recent Update on the Clinical Trials and Effectiveness of Drugs Used in COVID-19, MERS and SARS Coronaviruses
Anti-Infective Agents

FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data
Combinatorial Chemistry & High Throughput Screening

Steroidal Conjugates and Their Pharmacological Applications
Current Medicinal Chemistry

Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry

Cardiac (myo)fibroblast: Novel Strategies for its Targeting Following Myocardial Infarction
Current Pharmaceutical Design

Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Current Vascular Pharmacology

MicroRNAs Patents: The Road From Bench to Bedsides for Cancer Treatment
Recent Patents on DNA & Gene Sequences

Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Current Clinical Pharmacology

Bv8-Prokineticins and their Receptors: Modulators of Pain
Current Pharmaceutical Biotechnology

Investigating the Effects of <i>Dorema hyrcanum</i> Root Extracts on Selective Induction of Programmed Cell Death in Glioblastoma, Ovarian Cancer and Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry

Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation
Current Drug Targets

SALL4: Engine of Cell Stemness
Current Gene Therapy

Multidrug Resistance Through the Spectacle of P-Glycoprotein
Current Cancer Drug Targets

© 2024 Bentham Science Publishers | Privacy Policy